pharmaceuticals

Laurus Labs Limited Q3 FY23 Earnings Conference Call Insights

● Jan 31, 2023

Key highlights from Laurus Labs Limited (LAURUSLABS) Q3 FY23 Earnings Concall Management Update: [00:03:57] LAURUSLABS said its strong results were...

Glenmark Life Sciences Limited Q3 FY23 Earnings Conference Call Insights

● Jan 30, 2023

Key highlights from Glenmark Life Sciences Limited (GLS) Q3 FY23 Earnings Concall Q&A Highlights: [00:13:44] Tarang Agrawal of Old Bridge...

Laurus Labs Limited Q3 FY23; Consolidated Revenue Jumps By 50%

● Jan 30, 2023

Laurus Labs Limited (NSE: LAURUSLABS) reported Revenue from Operations for Q3 FY23 of ₹1,544.82 Crore up from ₹1028.76 Crore year...

Torrent Pharmaceuticals Ltd Q3 FY23 Earnings Conference Call Insights

● Jan 27, 2023

Key highlights from Torrent Pharmaceuticals Ltd (TORNTPHARM) Q3 FY23 Earnings Concall Management Update: [00:05:39] TORNTPHARM said the company expects to...

Torrent Pharmaceuticals Ltd (TORNTPHARM) Q3 FY23 Earnings Concall Transcript

● Jan 25, 2023

Torrent Pharmaceuticals Ltd (NSE: TORNTPHARM) Q3 FY23 Earnings Concall dated Jan. 25, 2023 Corporate Participants: Sudhir Menon — Executive Director, (Finance) and...

Infographic Ltd.(NSE: DRREDDY) | Q3 FY23 Results | Total Income rises +7.47% qoq

● Jan 25, 2023

Dr. Reddy’s Laboratories (NSE: DRREDDY) is an Indian multinational pharmaceutical company. Founded in 1984, the company primarily develops and sells...

Infographic Cipla Ltd.(NSE: CIPLA) | Q3 FY23 Results | Total Income falls -0.45% qoq

● Jan 25, 2023

Cipla Limited (NSE: CIPLA) is an Indian multinational pharmaceutical and biopharmaceutical company. Founded in 1935, Cipla primarily develops and sells...

Gland Pharma Limited Q3 FY23 Earnings Conference Call Insights

● Jan 24, 2023

Key highlights from Gland Pharma Limited (GLAND) Q3 FY23 Earnings Concall Management Update: [00:06:08] GLAND said the insulin line is...

Gland Pharma Limited Q3 FY23; Net Profit Down To 232 Crore

● Jan 23, 2023

Gland Pharma Limited (NSE: GLAND) reported Revenue from Operations of ₹938.28 Crore down from ₹1,063.32 Crore year on year, a...

Marksans Pharma(NSE:MARKSANS): Everything You Need to Know | Stock up 30% in 3 Months

● Jan 4, 2023

Marksans Pharma (NSE:MARKSANS) is a mid-sized pharmaceutical company with a large presence in the US, UK, Australia, and New Zealand...